Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery.
Dimitrios NasioudisXiaolei WangGurdial DhillonNawar LatifEmily M KoRobert L GiuntoliDavid M GershensonAmanda FaderMark CareyFiona SimpkinsPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Adjuvant chemotherapy may not be associated with an overall survival benefit for patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery.